cyc 202 has been researched along with guanine in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (guanine) | Trials (guanine) | Recent Studies (post-2010) (guanine) |
---|---|---|---|---|---|
979 | 7 | 393 | 16,278 | 822 | 4,809 |
Protein | Taxonomy | cyc 202 (IC50) | guanine (IC50) |
---|---|---|---|
Purine nucleoside phosphorylase | Homo sapiens (human) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferguson, M; Fersht, A; Finlan, L; Hupp, TR; Ibbotson, S; Luciani, MG; Rankin, EM | 1 |
1 other study(ies) available for cyc 202 and guanine
Article | Year |
---|---|
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Topics: Antineoplastic Agents; Binding Sites; CDC2-CDC28 Kinases; Cell Death; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Guanine; Humans; Mutation; Peptide Fragments; Phosphorylation; Protein Binding; Purines; Roscovitine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2004 |